What is the normal range of calcitonin (calcitonin) levels in children between 1 to 5 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Calcitonin Values in Children Ages 1-5

The normal range of calcitonin in children aged 1-5 years is gender-dependent, with significantly higher values in boys than girls, and shows an accelerated decline from infancy to approximately age 4-5 years for both sexes. 1

Age and Gender-Specific Reference Ranges

Calcitonin levels in children demonstrate clear age and gender dependencies that must be considered when interpreting results:

  • Calcitonin levels are significantly higher in boys than girls (p<0.01) 1
  • Both genders show an accelerated decline in calcitonin levels from infancy until approximately 4-5 years of age 1
  • After age 5, the decline continues but at a slower rate

Clinical Interpretation Guidelines

When evaluating calcitonin levels in children aged 1-5:

  • Use gender-specific reference ranges to properly interpret results
  • Consider that calcitonin levels naturally decrease during this age period
  • Be aware that using adult reference ranges can lead to misinterpretation of results

Factors Affecting Calcitonin Levels

Several factors can influence calcitonin measurements in children:

  • Calcium levels (calcium is a primary secretagogue for calcitonin) 2
  • Renal function (impaired kidney function can elevate calcitonin) 2
  • Certain medications (e.g., β-blockers can affect results) 2
  • Thyroid diseases (though these have minimal impact, affecting only about 1.5% of pediatric patients) 1

Clinical Applications

The primary clinical application for calcitonin measurement in children is screening for medullary thyroid carcinoma (MTC), particularly in those with:

  • Multiple endocrine neoplasia type 2 (MEN 2)
  • Family history of MTC
  • RET proto-oncogene mutations

For children with high-risk RET mutations, the National Comprehensive Cancer Network and American Thyroid Association recommend prophylactic total thyroidectomy by age 5, regardless of calcitonin levels 3.

Measurement Considerations

  • Use highly sensitive immunoassays specifically validated for pediatric populations
  • The electrochemiluminescence immunoassay (ECLIA) has been validated in large pediatric cohorts 1
  • Interpret results using age and gender-specific reference ranges
  • Consider calcium stimulation testing for borderline results, though this is less commonly needed with modern sensitive assays

Common Pitfalls to Avoid

  1. Using adult reference ranges for pediatric patients
  2. Failing to account for gender differences in reference ranges
  3. Not considering the natural decline in calcitonin levels during early childhood
  4. Overlooking non-MTC causes of elevated calcitonin (renal insufficiency, certain medications)

The establishment of proper pediatric reference ranges from large cohorts of healthy children has significantly improved the laboratory monitoring of calcitonin in pediatric patients, particularly those with MEN 2 and suspected MTC 1.

References

Research

Calcitonin: current concepts and differential diagnosis.

Therapeutic advances in endocrinology and metabolism, 2022

Guideline

Management of Medullary Thyroid Carcinoma in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.